Soo-yeon Jung

Title: The Innovations of Soo-yeon Jung

Introduction

Soo-yeon Jung is a prominent inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for cancer treatment. With a total of 2 patents, his work is recognized for its potential impact on medical therapies.

Latest Patents

Soo-yeon Jung's latest patents include an antibody specifically binding to an epitope in the SEMA domain of c-Met. This invention involves an antibody or antigen binding fragment that specifically targets an epitope in the c-Met protein, along with pharmaceutical compositions, methods, kits, nucleic acids, and cells related to this discovery. Another notable patent is the anti c-Met humanized antibody and its uses, which provides a method for preventing or treating cancer by administering a composition that includes this antibody.

Career Highlights

Soo-yeon Jung is currently employed at Samsung Electronics Co., Ltd., where he continues to innovate in the field of biotechnology. His work at this leading technology company allows him to collaborate with other experts and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Kyung-ah Kim and Kwang-ho Cheong, who work alongside him in advancing their shared goals in research and development.

Conclusion

Soo-yeon Jung's contributions to biotechnology, particularly in cancer treatment, highlight his role as an influential inventor. His patents reflect a commitment to improving medical therapies and advancing scientific knowledge.